Cargando…
Rescue therapy with rifabutin regimen for refractory Helicobacter pylori infection with dual drug-resistant strains
BACKGROUND: There is no current standard rescue treatment for dual drug-resistant strains of Helicobacter pylori (H. pylori). This aim of this study was to investigate the efficacy of rifabutin-based triple therapy for patients infected with dual drug-resistant strains to clarithromycin and levoflox...
Autores principales: | Kuo, Chia-Jung, Lin, Cheng-Yu, Le, Puo-Hsien, Chang, Pi-Yueh, Lai, Chih-Ho, Lin, Wey-Ran, Chang, Ming-Ling, Hsu, Jun-Te, Cheng, Hao-Tsai, Tseng, Chi-Nan, Lin, Chun-Jung, Su, Ming-Yao, Hsieh, Sen-Yung, Chiu, Cheng-Tang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350721/ https://www.ncbi.nlm.nih.gov/pubmed/32650737 http://dx.doi.org/10.1186/s12876-020-01370-4 |
Ejemplares similares
-
Rifabutin-based High-dose Proton-pump Inhibitor and Amoxicillin Triple Regimen as the Rescue treatment for Helicobacter pylori
por: Lim, Hyun Chul, et al.
Publicado: (2014) -
Efficacy of dexlansoprazole-based triple therapy for
Helicobacter pylori infections
por: Kuo, Chia-Jung, et al.
Publicado: (2019) -
Rifabutin and Furazolidone Could Be the Candidates of the Rescue Regimen for Antibiotic-Resistant H. pylori in Korea
por: Choi, Youn I, et al.
Publicado: (2019) -
Rifabutin for the Treatment of Helicobacter pylori Infection: A Review
por: Gisbert, Javier P.
Publicado: (2020) -
Comments regarding use of rifabutin for Helicobacter pylori eradication
por: Graham, David Y.
Publicado: (2021)